SCM
Stonepine Capital Management Portfolio holdings
AUM
$102M
This Quarter Return
+131.02%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$143M
AUM Growth
+$143M
(+39%)
Cap. Flow
+$1.89M
Cap. Flow
% of AUM
1.31%
Top 10 Holdings %
Top 10 Hldgs %
81.78%
Holding
32
New
6
Increased
11
Reduced
6
Closed
9
Top Buys
| 1 |
AFMD
Affimed
AFMD
|
$10.8M |
| 2 |
AMRN
Amarin Corp
AMRN
|
$6.68M |
| 3 |
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
|
$5.65M |
| 4 |
Evolus
EOLS
|
$4.81M |
| 5 |
Gyre Therapeutics
GYRE
|
$2.09M |
Top Sells
| 1 |
BDSI
BioDelivery Sciences International, Inc.
BDSI
|
$10.9M |
| 2 |
Enanta Pharmaceuticals
ENTA
|
$7.8M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$7.09M |
| 4 |
Ligand Pharmaceuticals
LGND
|
$2.98M |
| 5 |
ALIM
Alimera Sciences, Inc.
ALIM
|
$1.55M |
Sector Composition
| 1 | Healthcare | 92.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMRN
1
Amarin Corp
AMRN
$311M
| $33.3M | 23.18% | 1,551,300 +311,732 | +25% | +$6.68M |
|
|
ISEE
2
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $25.7M | 17.94% | 3,000,000 -825,903 | -22% | -$7.09M |
|
|
AFMD
3
DELISTED
Affimed
AFMD
| $11M | 7.66% | 4,010,155 +3,931,655 | +5,008% | +$10.8M |
|
|
OXFD
4
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $10.5M | 7.3% | 630,862 -50,950 | -7% | -$846K |
|
|
ADMS
5
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $8.49M | 5.92% | 2,241,239 +1,490,227 | +198% | +$5.65M |
|
|
NEOS
6
DELISTED
Neos Therapeutics, Inc
NEOS
| $7.34M | 5.11% | 4,858,889 +356,588 | +8% | +$538K |
|
|
CTIC
7
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $5.93M | 4.14% | 3,755,000 +43,001 | +1% | +$67.9K |
|
8
Xoma
XOMA
$392M
| $5.48M | 3.82% | 200,667 -29,534 | -13% | -$806K |
|
|
OPNT
9
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
| $4.81M | 3.36% | 334,272 +20,199 | +6% | +$291K |
|
|
10
Evolus
EOLS
$494M
| $4.81M | 3.35% | +394,890 | New | +$4.81M |
|
|
APEN
11
DELISTED
Apollo Endosurgery, Inc.
APEN
| $4.71M | 3.28% | 1,651,333 +188,145 | +13% | +$536K |
|
12
Cumberland Pharmaceuticals
CPIX
$52.2M
| $4.62M | 3.22% | 896,170 +35,721 | +4% | +$184K |
|
|
HTGM
13
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
| $3.34M | 2.33% | 4,758,426 -1,031,843 | -18% | -$724K |
|
|
NVLN
14
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
| $2.76M | 1.92% | 3,909,207 +205,787 | +6% | +$145K |
|
15
Aptevo Therapeutics
APVO
$5.39M
| $2.74M | 1.91% | 4,179,131 +765,710 | +22% | +$501K |
|
|
16
Gyre Therapeutics
GYRE
$703M
| $2.09M | 1.46% | +307,287 | New | +$2.09M |
|
|
CHMA
17
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $911K | 0.64% | 183,660 +73,917 | +67% | +$367K |
|
|
SBBP
18
DELISTED
Strongbridge Biopharma plc.
SBBP
| $903K | 0.63% | +431,853 | New | +$903K |
|
19
SCYNEXIS
SCYX
$34.9M
| $555K | 0.39% | +609,384 | New | +$555K |
|
|
IDXG
20
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
| $472K | 0.33% | 943,851 -216,527 | -19% | -$108K |
|
21
Adicet Bio
ACET
$59.9M
| $122K | 0.09% | +81,772 | New | +$122K |
|
|
ACER
22
DELISTED
Acer Therapeutics Inc. Common Stock (DE)
ACER
| $80K | 0.06% | 20,000 -94,175 | -82% | -$377K |
|
23
DiaMedica Therapeutics
DMAC
$295M
| – | – | -13,705 | Closed | -$28K |
|
24
DURECT Corp
DRRX
$59.6M
| – | – | -100,000 | Closed | -$184K |
|
|
25
Enanta Pharmaceuticals
ENTA
$180M
| – | – | -129,867 | Closed | -$7.8M |
|